|
|
||||||||
1 Department of Physiology and Biophysics, Wright State University School of Medicine, Dayton, Ohio 45435-0927; 2 Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, Georgia 30912-2300; 3 Michael E. DeBakey Institute for Comparative Cardiovascular Science and Department of Veterinary Physiology and Pharmacology, Texas A & M University College of Veterinary Medicine, College Station, Texas 77843-4466; and 4 Department of Physiology, Northeastern Ohio Universities College of Medicine, Rootstown, Ohio 44272
| |
ABSTRACT |
|---|
|
|
|---|
Cardiovascular diseases are often considered to be a predominantly male health problem, and it has been suggested that testosterone exerts deleterious effects on cardiovascular function; however, few experimental studies support this suggestion. Moreover, the cellular and molecular mechanism(s) underlying vascular responses to testosterone is unknown. The present study has investigated the acute effects of testosterone on porcine coronary artery smooth muscle at the tissue and cellular levels. Contractile studies demonstrated that testosterone or dihydrotestosterone (a nonaromatizable metabolite) relaxed these arteries by an endothelium-independent mechanism involving potassium efflux. Direct evidence from patch-clamp studies confirmed that testosterone opened K+ channels in single coronary myocytes, and further analysis identified this protein as the large-conductance, calcium- and voltage-activated potassium (BKCa) channel. Moreover, inhibiting BKCa channel activity significantly attenuated testosterone-induced coronary relaxation. These findings indicate that testosterone relaxes porcine coronary arteries predominantly by opening BKCa channels in coronary myocytes, and this response may be associated with accumulation of cGMP. This novel mechanism may provide a better understanding of testosterone-induced vasorelaxation reported in recent experimental and early clinical studies.
steroid; vascular; ion channel; vasodilation; androgen
| |
INTRODUCTION |
|---|
|
|
|---|
THE INCIDENCE OF CARDIOVASCULAR disease is influenced by both gender and age. For example, the risk of developing coronary artery disease or hypertension is much higher in men than in premenopausal women; however, by the age of 65 years a woman is just as likely to suffer cardiovascular dysfunction as a man of similar age (12, 14). Therefore, it has been proposed that gonadal steroids influence cardiovascular physiology and/or pathophysiology. Specifically, it has been proposed that estrogen may protect against the development of cardiovascular diseases; however, the administration of exogenous estrogen in men may actually increase the risk of death from coronary artery disease (1). Testosterone, on the other hand, is often considered to exacerbate the development of cardiovascular diseases; however, clinical and epidemiological studies of the relationship between testosterone and cardiovascular disease are at best controversial. For example, plasma testosterone levels are reported to correlate either positively or negatively with the incidence of coronary artery disease in men (3, 17). In fact, testosterone is associated with higher levels of high-density lipoprotein in men and was correlated negatively with risk factors such as fibrinogen, plasminogen activator inhibitor-1, and insulin (16), suggesting that hypotestosteronemia may be a risk factor for coronary atherosclerotic heart disease in men. In addition, plasma androgen levels are higher in normotensive males than in their hypertensive counterparts (12). Interestingly, potential therapeutic effects of testosterone on angina pectoris were first reported over 50 years ago (10, 21), with more recent electrocardiographic studies demonstrating that testosterone relieves exercise-induced S-T segment depression (11). In light of these studies, it seems premature to conclude that testosterone promotes cardiovascular dysfunction. Instead, a better understanding of the cellular and molecular effects of testosterone on the cardiovascular system is needed before any definitive conclusions can be made regarding the role of testosterone in cardiovascular disease.
Recent in vitro studies revealed that testosterone produces acute (within minutes) endothelium-independent relaxation of rabbit coronary arteries (24). More recent studies from our laboratory demonstrated that testosterone-induced relaxation of the rat aorta is gender and androgen receptor independent and involves both endothelium-dependent and -independent mechanisms (4). Endothelium-dependent and endothelium-independent vasodilatory effects of testosterone were also described in canine coronary conductance and resistance arteries in vivo (2). Interestingly, pharmacological evidence from each of these previous studies suggests that testosterone-induced vascular relaxation might involve potassium efflux; however, to our knowledge, no studies have yet investigated potential effects of testosterone on potassium channels directly with the patch-clamp technique nor has an effect of testosterone on porcine coronary arteries been reported. The purpose of the present study was to assess the direct effect of testosterone on porcine coronary arteries and single myocytes from these vessels. Using isometric coronary vascular preparations and single-channel, patch-clamp recordings, we have identified a specific large-conductance, calcium- and voltage-activated potassium (BKCa) channel as the primary effector mediating testosterone-induced relaxation of porcine coronary arteries.
| |
METHODS |
|---|
|
|
|---|
Arterial tension studies. Fresh porcine hearts from castrated males or gilts were obtained from local abattoirs. The left anterior descending (LAD) artery was excised and placed in ice-cold, low-calcium dissociation medium (DM) of the following composition (in mM): 110 NaCl, 5 KCl, 0.16 CaCl2, 2 MgCl2, 10 HEPES, 10 NaHCO3, 0.5 KH2PO4, 0.5 NaH2PO4, 10 glucose, 0.49 EDTA, and 10 taurine (pH 6.9). The arteries were kept on ice during their transport to the laboratory. Arterial rings (length, 2 to 4 mm) were prepared from the LADs and mounted in organ baths for isometric tension recording using standard methods. The endothelium was removed in some rings by passing a frayed nylon string through the vessel lumen and gently rubbing the intimal surface. The arterial rings were suspended in organ baths containing Krebs-Henseleit bicarbonate (KHB) solution (37°C, gassed with 95% O2-5% CO2) of the following composition (in mM): 122 NaCl, 4.7 KCl, 15.5 NaHCO3, 1.8 CaCl2, 1.2 MgCl2, 1.2 KH2PO4, and 11 glucose (pH 7.4). Preparations were equilibrated for 90 min at an optimal passive tension of 2.5 g. Fresh KHB solution was added every 20 min.
After equilibration, rings were stabilized by two successive maximal contractions with 80 mM KCl-KHB (NaCl was replaced with KCl to maintain normal osmolality). The tissues were then allowed to relax and reequilibrate for 30-45 min before further experimentation. Rings were then precontracted with PGF2
(10
5 M).
After a stable contractile tension was attained, testosterone was added
to the baths in a cumulative manner to obtain a complete concentration-response relationship for each ring (5-75 µM). In some experiments, potassium channel inhibitors were added to the bath
25-30 min before testosterone. All drug solutions were prepared fresh daily. Vehicle and time-control experiments were also performed to control for potential effects of ethanol on vasorelaxation and to
determine the stability of PGF2
-induced precontraction. We did not observe differences in vascular reactivity between arteries
from female or castrated male pigs.
Isolation of coronary arterial myocytes. Myocytes were isolated from a 3-cm segment of the LAD artery as described previously (22). After the endothelium and adventitia were removed, the tissue was cut into 1-mm strips and placed in the low-calcium DM described above. The strips were then incubated at 37°C in 5 ml of DM containing 5 mg of papain, 4 mM dithiothreitol, and 0.2% bovine serum albumin. After 30 min of gentle shaking, the strips were triturated for 3-5 min, and enzyme activity was terminated by addition of excess enzyme-free cold DM. The solution was then removed and centrifuged at low speed for 6 min. The resultant pellet was resuspended in fresh DM and kept at 4°C.
Patch-clamp studies.
Several drops of cell suspension were placed in a recording
chamber (Warner Instruments). Single potassium channels were measured in cell-attached patches by filling the patch pipette (2-5 M
) with Ringer solution of the following composition (in mM): 140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, and 10 HEPES (pH 7.4;
22-25°C). Voltage across the patch was controlled by setting the
cellular membrane potential to 0 mV using a high potassium
extracellular solution of (in mM) 140 KCl, 10 MgCl2, 0.1 CaCl2, 10 HEPES, and 30 glucose (pH 7.4). After a gigaohm
seal on a single myocyte was made, currents were elicited by a series
of membrane depolarizations. Currents were filtered at 1 kHz and
digitized at 10 kHz. Average channel activity in patches with multiple
BKCa channels was measured as mean open probability times
the number of open channels (NPo), as
described previously (22). For consistency, statistics on channel activity were reported at a membrane potential of +40 mV.
Although the effect of testosterone was observed at a variety of
potentials, BKCa channels are very clearly identified at
+40 mV, thus increasing the accuracy and reliability of
NPo calculations. The number of experiments
reported refers to the number of patches studied. In experiments
recording potassium channel activity of inside-out patches, the bathing
solution exposed to the cytoplasmic surface of the membrane consisted
of the following low-calcium solution (in mM): 60 K2SO4, 30 KCl, 2 MgCl2, 1 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid,
0.16 CaCl2 (pCa 7), 10 HEPES, 5 ATP, and 10 glucose (pH 7.4; 22-25°C)
Biochemical analysis. cGMP was measured as described previously (23) by using an enzyme immunometric assay kit (Biomol) that included all reagents, antibodies, and microtiter plates. Briefly, endothelium-denuded media strips from coronary arteries were exposed to a single concentration of either 10 µM or 50 µM testosterone or 10 µM sodium nitroprusside (as a positive control) for 30 min with 10 µM 3-isobutyl-1-methylxanthine to inhibit phosphodiesterase activity. Reactions were stopped by adding 0.1 N HCl and boiling for 5 min. The precipitated protein was removed by centrifugation. After colorimetric analysis, nucleotide levels were expressed as femtomoles of nucleotide per milligram tissue weight.
Statistical analysis. Statistical significance between two groups was evaluated by Student's t-test for paired data. Comparison among multiple groups were made using a one-way ANOVA test, followed by Tukey's test post hoc to determine significant differences among the means of the data groups. A probability of P < 0.05 was accepted as a significant difference. For functional studies, n = number of porcine hearts employed in the study; for patch-clamp studies, n = number of patches studied.
Drugs. 1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid was purchased from Calbiochem. All other agents were purchased from Sigma.
| |
RESULTS |
|---|
|
|
|---|
Arterial tension studies.
Testosterone produced concentration-dependent relaxation of coronary
arterial ring preparations precontracted with PGF2
. A
complete concentration-response relationship for testosterone-induced relaxation of intact arteries is illustrated in Fig.
1, which reveals that testosterone (75 µM) induces a nearly complete relaxation of 97.4 ± 1%
(n = 6). In contrast, precontracted preparations exposed to ethanol (vehicle control) or PGF2
alone (time control) relaxed no more than an average of 11.3 ± 2%. The
sensitivity (EC50 value) of coronary arterial rings to
testosterone-induced relaxation was 26.4 ± 4 µM. The importance
of endothelium in mediating testosterone-induced coronary arteries
relaxation was investigated by obtaining a series of complete
concentration-responses relationships (Fig.
2). In these experiments, removal of the
endothelium resulted in a slight but insignificant shift in the
testosterone response curve (EC50 values: 31.3 ± 4.8 µM, intact arteries; 44.4 ± 9.7 µM, endothelium removed;
n = 7; P > 0.05). A similar effect was observed when intact arteries were pretreated for 30 min with 250 µM
N
-nitro-L-arginine methyl ester
(EC50 value, 39.3 ± 3.5 µM; n = 7 arteries), an inhibitor of nitric oxide synthesis. Furthermore, the
maximal relaxation response was similar under all conditions tested
(~85%, n = 28 arteries). Because these findings are
consistent with previous studies indicating that testosterone induces
endothelium-independent relaxation of coronary arteries
(24), subsequent tension studies employed
endothelium-denuded coronary rings to control for potential indirect
effects of vasoactive factors released from endothelium.
|
|
(Fig. 3)
and exhibited a time course similar to that of testosterone-induced
relaxation (Fig. 4).
|
|
relaxed
77.2 ± 4.1% (n = 8 arteries) in response to a
single exposure to 25 µM testosterone (Fig. 4A). In
contrast, this same concentration of testosterone produced an average
relaxation of only 5.1 ± 1.4% in the same artery precontracted
with 80 mM KCl (n = 6). These findings indicate that
the majority (~94%) of testosterone-induced coronary relaxation
requires potassium gradients suitable for K+ efflux and
further suggested potential involvement of K+ channels.
Furthermore, pretreating coronary arteries with 1-2 mM
tetraethylammonium (TEA) induced a contraction relatively resistant to
testosterone (Fig. 4B): 25 µM testosterone (with 5 mM
[K+]o) produced only 8.2 ± 1.1%
relaxation (n = 6) of TEA-contracted arteries, a
response similar to the blunted effect observed in arteries
precontracted with 80 mM KCl. At these low concentrations, TEA is a
selective inhibitor of BKCa channels. Moreover,
testosterone produced only 12.6 ± 3.3% relaxation
(n = 6) in arteries precontracted with
PGF2
in the presence of 20 nM iberiotoxin (25 min), a
highly selective inhibitor of BKCa channels (Fig.
5). These studies on intact arteries
strongly suggested that testosterone induced coronary relaxation by
opening BKCa channels in coronary smooth muscle; however,
direct evidence for ion channel involvement cannot be obtained from
studies on intact tissues. To test the hypothesis that testosterone
opened K+ channels, patch-clamp experiments were performed
on isolated coronary myocytes to measure the activity of single
K+ channels directly.
|
Patch-clamp studies.
Conclusive evidence for testosterone-induced stimulation of
BKCa channel activity was obtained from patch-clamp
experiments on isolated coronary myocytes in which the activity of
single K+ channels was measured directly. Recordings from
excised inside-out patches demonstrated that membrane electrical
activity was dominated by a single species of high-amplitude channel
carrying outward current. Biophysical analysis of single-channel,
current-voltage relationships revealed a microscopic conductance of
221 ± 11 pS (n = 3-4 studies) in symmetrical
K+ gradients (140 mM; Fig.
6A). In addition,
channels were opened by increasing Ca2+ concentration
at the cytoplasmic surface of inside-out patches (1 µM;
NPo 0.39 ± 0.05; n = 4),
whereas 1 mM TEA blocked calcium-stimulated channel activity
(NPo 0.000; Fig. 6B;
n = 4). These findings identify this protein as the
BKCa channel, which other studies have demonstrated is the
predominant K+ channel expressed in myocytes from porcine
(22) or human (9) coronary arteries.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study is the first to report testosterone-induced relaxation of porcine coronary arteries in vitro. DHT, a nonaromatizable testosterone metabolite, also relaxed coronary arteries, suggesting that aromatization to estrogen is not required to produce this relaxation response. Furthermore, this response required physiological gradients of potassium, suggesting potential involvement of potassium channels. Subsequent patch-clamp studies provided direct molecular evidence that testosterone stimulates the activity of BKCa channels in single coronary myocytes, possibly via cGMP. Moreover, these cellular studies are completely consistent with functional studies of coronary arteries demonstrating that BKCa channels mediate nearly all of testosterone-induced relaxation. Iberiotoxin, a highly specific antagonist of BKCa channels, attenuated testosterone-induced coronary relaxation by 84% (Fig. 5). Therefore, we propose that stimulation of BKCa channel activity can account for the majority of testosterone-induced relaxation of porcine coronary arteries.
Recent studies demonstrated that testosterone relaxes rabbit coronary arteries or aorta (24) and rat thoracic aorta (4) in vitro and canine coronary arteries in vivo (2). Both endothelium-dependent and -independent effects of testosterone are reported in these studies. Therefore, testosterone may have multiple sites of action. In the present study on porcine coronary arteries, removal of the endothelium did not affect testosterone-induced coronary relaxation significantly; therefore, it is highly likely that the primary site of testosterone action in porcine coronary arteries is the vascular smooth muscle cell. Regardless of the target, it is clear that testosterone modulates the excitability of vascular smooth muscle, and the present study now provides direct molecular evidence that testosterone opens potassium channels in vascular smooth muscle cells. Furthermore, we have identified the BKCa channel as the primary effector molecule mediating this potassium efflux and subsequent relaxation of porcine coronary arteries. Myocytes from both human (9) and porcine (19) coronary arteries express BKCa channels at high density, and because of their large conductance, these channels help set and maintain the resting potential of vascular smooth muscle cells under physiological conditions (20). Moreover, inhibition of BKCa channels by TEA (Fig. 4B) or iberiotoxin (22) induces contraction of porcine coronary arteries in vitro, confirming the importance of these channels in regulating tension under either stimulated or unstimulated conditions. An additional feature of interest regarding these channels is their ability to provide a repolarizing negative-feedback mechanism to reverse active contraction due to increased intracellular levels of calcium. Because single-channel studies clearly demonstrated increased BKCa channel activity to be the predominant effect of testosterone, we conclude that the BKCa channel is an important effector of testosterone in these myocytes. Previous in vitro studies reported that glibenclamide, an inhibitor of the ATP-sensitive potassium channel, had no effect on testosterone-induced relaxation of rabbit coronary arteries (24), although a subsequent study reported that this compound reduced the effect of testosterone on smaller resistance coronary vessels in the dog (2). In addition, neither glibenclamide nor 1 mM TEA inhibited testosterone-induced relaxation of the rat aorta, whereas 4-aminopyridine attenuated the response to testosterone by 44% (7). Taken together, these findings suggest that the nature of potassium channel stimulation by testosterone may be heterogeneous with respect to artery and/or species. However, the identity of K+ channel(s) stimulated in these arteries will remain somewhat speculative until patch-clamp studies are performed on myocytes isolated from each vessel. In contrast, the present study now provides direct evidence that BKCa channel activity is stimulated by testosterone in porcine coronary arteries. In support of our findings, a recent study by Crews and Khalil (5) has demonstrated that testosterone inhibits 45Ca2+ influx in porcine coronary arteries but does not affect release of intracellular calcium. These findings are consistent with those of the present study that strongly suggest that testosterone inhibits calcium channel activity by opening BKCa channels, resulting in hyperpolarization of the vascular cell membranes and closing of the voltage-dependent calcium channels.
Although the present studies have identified an effector molecule (BKCa channel) that mediates testosterone-induced relaxation of coronary arteries, the complete transduction mechanism involved in this process remains to be elucidated. One signaling molecule in this process appears to be cGMP, which is increased in coronary smooth muscle after treatment with testosterone (Fig. 8B). Furthermore, studies on cell-attached patches verified that cGMP also opened BKCa channels in single coronary myocytes, thus mimicking the effect of testosterone on these cells. Therefore, evidence from both functional and biochemical studies is consistent with the hypothesis that cGMP mediates the effect of testosterone on porcine coronary arteries. However, the present study cannot exclude involvement of other potential signaling mechanism. Although it is unclear at present how androgens might stimulate production of cGMP in vascular smooth muscle in the absence of endothelium, a similar nongenomic, nucleotide-dependent mechanism of action has been proposed for other gonadal steroids. For example, estrogen also increases cGMP accumulation and stimulates BKCa channel activity in coronary smooth muscle (6).
Because testosterone and estrogen produce similar effects in coronary smooth muscle cells, it was possible that the stimulatory effects of testosterone were actually indirect, i.e., due to aromatization to estrogen. However, the present study suggests that testosterone-induced relaxation of porcine coronary arteries probably involves a direct effect of the androgen molecule on the vasculature. A nonaromatizable metabolite of testosterone, DHT, produced a similar vasodilatory effect in a similar time frame, albeit with an apparently lower sensitivity. This finding is consistent with previous studies of the rat aorta (8) demonstrating that testosterone-induced relaxation was a structurally-specific effect of the androgen molecule. In that study, maximal relaxation by DHT (69%) was substantially less than that produced by testosterone (100%). Furthermore, previous studies have demonstrated that inhibition of aromatase activity with aminoglutethimide had no effect on testosterone-induced relaxation of rabbit coronary arteries (24). Therefore, the present results are consistent with previous findings obtained in other arteries and suggest a direct vasodilatory effect of testosterone that is not likely to depend on conversion to estrogen or other vasoactive steroids. Although it is possible that testosterone is converted to DHT in the vessel wall, this seems unlikely because in virtually all other nonreproductive target tissues, the biological actions of testosterone do not require conversion to DHT. Furthermore, if conversion of testosterone to DHT occurred to any significant extent, then the vasodilatory efficacy and potency of these two androgens should be the same, but evidence from three other androgen analog studies establishes that this is definitely not the case (8, 13, 24). Previous studies have also established that testosterone-induced vascular relaxation is independent of the classical androgen receptor (4). In fact, testosterone conjugated with bovine serum albumin produced a greater relaxation of the rat aorta compared with unconjugated testosterone (8), implicating involvement of a peripheral cell membrane (nonnuclear) site of action. In addition, previous studies of the rabbit coronary artery reported that an androgen receptor antagonist had no effect on testosterone-induced relaxation (24). If testosterone does indeed activate an androgen receptor in porcine coronary arteries, it seems unlikely that this process would involve the classic genomic pathway, because the relaxation effect of testosterone occurs within minutes, not hours.
Although the present study provides convincing evidence that the BKCa channel is the effector molecule mediating testosterone-induced relaxation of porcine coronary arteries in vitro, low micromolar concentrations were required to obtain maximal relaxation of isolated tissues. These findings are consistent with previous studies, which also demonstrated that micromolar concentrations of testosterone were required to produce relaxation of intact arteries in vitro (4, 7, 8, 24). In contrast, lower concentrations of testosterone stimulated BKCa currents in single coronary myocytes. This is consistent with the in vivo studies of Chou et al. (2), which indicated 100 nM testosterone increased coronary blood flow significantly. Once again, however, micromolar concentrations of testosterone were required to produce maximal responses. The apparent greater sensitivity of isolated cells could result from the substantial differences in diffusion distance, tissue equilibration and the resultant cellular concentrations of testosterone that would be expected between single myocytes and the much thicker and histologically more complex structure of the intact vessel wall. The multiple concentric layers of collagen and elastin as well as vascular smooth muscle cells provide diffusion barriers that are absent in preparations of isolated cells, and the present study is the first to demonstrate effects of testosterone on single vascular myocytes. To our knowledge, all studies examining the vasodilatory effects of testosterone employ concentrations of testosterone in excess of the high picomolar-nanomolar levels of free hormone found in the plasma under normal conditions. The traditional view has been that only free steroid hormone is biologically active in target tissues. However, simple diffusion of free hormone cannot completely account for the biological activity of testosterone (18). Moreover, recent findings by Ding and Stallone (8) indicate that protein-bound testosterone is actually more efficacious in producing acute vascular relaxation than unbound testosterone. In addition, there is now increasing evidence that plasma levels of steroid hormones do not necessarily correspond to the actual effective intracellular concentrations and that target tissues can accumulate steroid hormones and sex hormone binding globulins (15). Thus accumulating evidence suggests that testosterone concentrations that exceed the "normal" low nanomolar levels are indeed physiologically relevant. Nonetheless, a direct correlation between in vitro experimental data and in vivo conditions will remain somewhat problematic until there is a better understanding of the actual effective intracellular concentration of steroid hormones in target cells.
In summary, the primary goal of this study was to determine the effects of testosterone on porcine coronary arteries. Testosterone induces endothelium-independent relaxation of this vessel, and results from both tissue and single-cell experiments demonstrate that this response primarily involves stimulation of BKCa channel activity. Understanding the signaling mechanisms that couple testosterone receptor activation to K+ channel stimulation will provide a better understanding of the cellular processes underlying the vasorelaxant effects of testosterone. Such future studies will further underscore the importance of steroid hormones in regulating cardiovascular function and also in treating and/or preventing diseases of the heart and blood vessels.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Landes Meats and Bob Evans Farms for their kind cooperation.
| |
FOOTNOTES |
|---|
This work was supported by a State of Ohio Research Challenge Foundation grant (to J. N. Stallone and R. E. White), by National Heart, Lung, and Blood Institute Grants HL-54844 and HL-64779 (to R. E. White) and HL-47432 (to J. N. Stallone), and by American Heart Association Grant 995017N (to R. E. White).
Address for reprint requests and other correspondence: R. E. White, Dept. Pharmacology & Toxicology, Medical College of Georgia, Augusta, GA 30912-2300 (E-mail: rwhite{at}mail.mcg.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 10 March 2001; accepted in final form 22 June 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
The Coronary Drug Project Research Group.
The coronary drug project. Findings leading to discontinuation of the 25-mg day estrogen group.
JAMA
226:
652-657,
1973[ISI][Medline].
2.
Chou, TM,
Sudhir K,
Hutchison SJ,
Ko E,
Amidon TM,
Collins P,
and
Chatterjee K.
Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo.
Circulation
94:
2614-2619,
1996
3.
Chute, CG,
Baron JA,
Plymate SR,
Kiel DP,
Pavia AT,
Lozner EC,
O'Keefe T,
and
MacDonald GJ.
Sex hormones and coronary artery disease.
Am J Med
83:
853-859,
1987[ISI][Medline].
4.
Costarella, CE,
Stallone JN,
Rutecki GW,
and
Whittier FC.
Testosterone causes direct relaxation of rat thoracic aorta.
J Pharmacol Exp Ther
277:
34-39,
1996
5.
Crews, JK,
and
Khalil RA.
Antagonistic effects of 17
-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction.
Arterioscler Thromb Vasc Biol
19:
1034-1040,
1999
6.
Darkow, DJ,
Lu L,
and
White RE.
Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP.
Am J Physiol Heart Circ Physiol
272:
H2765-H2773,
1997
7.
Ding, AO,
and
Stallone JN.
Testosterone-induced relaxation of rat thoracic aorta involves vascular smooth muscle K+ channel activation (Abstract).
FASEB J
10:
A706,
1996.
8.
Ding, AO,
and
Stallone JN.
Testosterone-induced relaxation of rat thoracic aorta: structural specificity of androgen analog effects on vascular smooth muscle and endothelium (Abstract).
FASEB J
11:
A264,
1997.
9.
Gollasch, M,
Ried C,
Bychkov R,
Luft FC,
and
Haller H.
K+ currents in human coronary artery vascular smooth muscle cells.
Circ Res
78:
676-688,
1996
10.
Hamm, L.
Testosterone propionate in the treatment of angina pectoris.
J Clin Endocrinol
2:
325-328,
1942.
11.
Jaffe, MD.
Effect of testosterone cypionate on postexercise ST segment depression.
Br Heart J
39:
1217-1222,
1977
12.
Khaw, KT,
and
Barrett-Connor E.
Blood pressure and endogenous testosterone in men: an inverse relationship.
J Hypertens
6:
329-332,
1988[ISI][Medline].
13.
Lawrence, WD,
Osawa YM,
Davis PJ,
and
Blas SD.
Structure-activity relationships of sex steroid analogs determined in vitro in a thyroid hormone-responsive membrane Ca2+-ATPase model.
Endocrinology
119:
2803-2808,
1986[Abstract].
14.
Messerli, FH,
Garavaglia GE,
Schmieder RE,
Sundgaard-Riise K,
Nunez BD,
and
Amodeo C.
Disparate cardiovascular findings in men and women with essential hypertension.
Ann Intern Med
107:
158-161,
1987.
15.
Noe, G,
Cheng YC,
Dabike M,
and
Croxatto HB.
Tissue uptake of human sex hormone-binding globulin and its influence on ligand kinetics in the adult female rat.
Biol Reprod
47:
970-976,
1992[Abstract].
16.
Phillips, GB,
Pinkernell BH,
and
Jing TY.
The association of hypotestosteronemia with coronary artery disease in men.
Arterioscler Thromb
14:
701-706,
1994
17.
Sewdarsen, M,
Jialal I,
Vythilingum S,
and
Desai R.
Sex hormone levels in young Indian patients with myocardial infarction.
Arteriosclerosis
6:
418-421,
1986
18.
Siiteri, PK,
Murai JT,
Hammond GL,
Nisker JA,
Raymoure WJ,
and
Kuhn RW.
The serum transport of steroid hormones.
Recent Prog Horm Res
38:
457-510,
1982.
19.
Toro, L,
and
Scornik F.
Modulation of Ca-activated K channels from coronary smooth muscle.
In: Ion Channels of Vascular Smooth Muscle Cells and Endothelial Cells, edited by Sperelakis N,
and Kuriyama H.. New York: Elsevier, 1991, p. 111-124.
20.
Trieschmann, U,
and
Isenberg G.
Ca2+-activated K+ channels contribute to the resting potential of vascular myocytes. Ca2+-sensitivity is increased by intracellular Mg2+ions.
Pflügers Arch
414:
S183-S184,
1989.
21.
Walter, T.
The use of testosterone propionate and estrogenic substance in the treatment of essential hypertension, angina pectoris, and peripheral vascular disease.
J Clin Endocrinol
2:
560-568,
1942.
22.
White, RE,
Darkow DJ,
and
Lang JL.
Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism.
Circ Res
77:
936-42,
1995
23.
White, RE,
Kryman JP,
El-Mowafy AM,
Han G,
and
Carrier GO.
cAMP-dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BKCa channel activity in coronary artery smooth muscle cells.
Circ Res
86:
897-905,
2000
24.
Yue, P,
Chatterjee K,
Beale C,
Poole-Wilson PA,
and
Collins P.
Testosterone relaxes rabbit coronary arteries and aorta.
Circulation
91:
1154-1160,
1995
This article has been cited by other articles:
![]() |
O. Canguven and A. L. Burnett The Effect of 5 {alpha}-Reductase Inhibitors on Erectile Function J Androl, September 1, 2008; 29(5): 514 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Bukiya, J. Liu, L. Toro, and A. M. Dopico beta1 (KCNMB1) Subunits Mediate Lithocholate Activation of Large-Conductance Ca2+-Activated K+ Channels and Dilation in Small, Resistance-Size Arteries Mol. Pharmacol., August 1, 2007; 72(2): 359 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. King, P. V. Lovell, M. Rishniw, M. I. Kotlikoff, M. L. Zeeman, and D. P. McCobb beta2 and beta4 Subunits of BK Channels Confer Differential Sensitivity to Acute Modulation by Steroid Hormones J Neurophysiol, May 1, 2006; 95(5): 2878 - 2888. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Bowles, K. K. Maddali, V. K. Ganjam, L. J. Rubin, D. L. Tharp, J. R. Turk, and C. L. Heaps Endogenous testosterone increases L-type Ca2+ channel expression in porcine coronary smooth muscle Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2091 - H2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sierra-Ramirez, T. Morato, R. Campos, I. Rubio, C. Calzada, E. Mendez, and G. Ceballos Acute effects of testosterone on intracellular Ca2+ kinetics in rat coronary endothelial cells are exerted via aromatization to estrogens Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H63 - H71. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Littleton-Kearney and P. D. Hurn Testosterone as a Modulator of Vascular Behavior Biol Res Nurs, April 1, 2004; 5(4): 276 - 285. [Abstract] [PDF] |
||||
![]() |
K S Channer and T H Jones Cardiovascular effects of testosterone: implications of the "male menopause"? Heart, February 1, 2003; 89(2): 121 - 122. [Full Text] [PDF] |
||||
![]() |
A. Q. Ding and J. N. Stallone Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation J Appl Physiol, December 1, 2001; 91(6): 2742 - 2750. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |